DK1501804T3 - Isoquinolinderivat MAO-B-inhibitorer - Google Patents

Isoquinolinderivat MAO-B-inhibitorer

Info

Publication number
DK1501804T3
DK1501804T3 DK03725018T DK03725018T DK1501804T3 DK 1501804 T3 DK1501804 T3 DK 1501804T3 DK 03725018 T DK03725018 T DK 03725018T DK 03725018 T DK03725018 T DK 03725018T DK 1501804 T3 DK1501804 T3 DK 1501804T3
Authority
DK
Denmark
Prior art keywords
mao
inhibitors
isoquinoline derivative
isoquinoline
derivative
Prior art date
Application number
DK03725018T
Other languages
English (en)
Inventor
Sarmiento Rosa Maria Rodriguez
Andrea Cesura
Michelangelo Scalone
Andrew William Thomas
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1501804T3 publication Critical patent/DK1501804T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
DK03725018T 2002-04-26 2003-04-14 Isoquinolinderivat MAO-B-inhibitorer DK1501804T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02009253 2002-04-26
PCT/EP2003/003845 WO2003091219A1 (en) 2002-04-26 2003-04-14 Isoquinoline derivatives

Publications (1)

Publication Number Publication Date
DK1501804T3 true DK1501804T3 (da) 2009-10-12

Family

ID=29265896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03725018T DK1501804T3 (da) 2002-04-26 2003-04-14 Isoquinolinderivat MAO-B-inhibitorer

Country Status (31)

Country Link
US (1) US6818774B2 (da)
EP (1) EP1501804B1 (da)
JP (1) JP4322685B2 (da)
KR (1) KR100681585B1 (da)
CN (1) CN1310890C (da)
AR (1) AR039651A1 (da)
AT (1) ATE440821T1 (da)
AU (1) AU2003227614B2 (da)
BR (1) BR0309562A (da)
CA (1) CA2483461C (da)
DE (1) DE60328978D1 (da)
DK (1) DK1501804T3 (da)
ES (1) ES2329354T3 (da)
GT (1) GT200300095A (da)
HK (1) HK1080836A1 (da)
HR (1) HRP20040952A2 (da)
IL (1) IL164677A0 (da)
MX (1) MXPA04010537A (da)
MY (1) MY133527A (da)
NO (1) NO20044571L (da)
NZ (1) NZ535885A (da)
PA (1) PA8572001A1 (da)
PE (1) PE20040594A1 (da)
PL (1) PL373697A1 (da)
PT (1) PT1501804E (da)
RU (1) RU2318812C2 (da)
SI (1) SI1501804T1 (da)
TW (1) TWI278451B (da)
UY (1) UY27786A1 (da)
WO (1) WO2003091219A1 (da)
ZA (1) ZA200408281B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2558761T3 (es) * 2003-05-19 2016-02-08 Novartis Ag Compuestos y composiciones inmunosupresores
JP4575920B2 (ja) * 2003-05-19 2010-11-04 アイアールエム・リミテッド・ライアビリティ・カンパニー 免疫抑制化合物および組成物
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
KR101186386B1 (ko) 2003-08-29 2012-09-26 오노 야꾸힝 고교 가부시키가이샤 Ｓ１ｐ 수용체 결합능을 갖는 화합물 및 그 의약 용도
CN1874991A (zh) 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途
ATE411027T1 (de) * 2003-10-23 2008-10-15 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
AU2005250077B2 (en) 2004-03-01 2011-06-09 Idorsia Pharmaceuticals Ltd Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
KR101262400B1 (ko) 2004-12-13 2013-05-08 오노 야꾸힝 고교 가부시키가이샤 아미노카르복실산 유도체 및 그 의약 용도
EP1844033B1 (de) * 2005-01-28 2011-07-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur herstellung von isochroman und derivaten davon
BRPI0606187A2 (pt) 2005-02-25 2009-06-09 Hoffmann La Roche comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
AU2006329040C1 (en) * 2005-12-22 2011-12-08 Newron Pharmaceuticals S.P.A. 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators
CN101400348A (zh) * 2006-03-15 2009-04-01 埃科特莱茵药品有限公司 用于提高记忆功能的四氢异喹啉衍生物
EP2013209B1 (en) 2006-04-26 2011-01-19 Actelion Pharmaceuticals Ltd. Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists
KR101220182B1 (ko) * 2009-02-25 2013-01-11 에스케이바이오팜 주식회사 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법
CN105315204B (zh) * 2014-07-04 2018-02-09 中南大学 7‑氨基‑1,4‑二氢异喹啉‑3(2h)‑酮衍生物及其合成方法和用途
CN105585527B (zh) * 2015-12-17 2018-06-26 浙江工业大学 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用
CN105461626B (zh) * 2015-12-17 2018-05-08 浙江工业大学 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用
ES2961550T3 (es) * 2017-03-27 2024-03-12 Bristol Myers Squibb Co Derivados de isoquinolina sustituidos como inmunomoduladores
CN114591238B (zh) * 2022-03-25 2022-11-15 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类药物中间体的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448269B1 (en) * 1993-07-22 2002-09-10 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicycle compounds and pharmaceuticals containing them
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
US5731324A (en) * 1993-07-22 1998-03-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
JP3258027B2 (ja) 1996-03-15 2002-02-18 サマーセット・ファーマシューティカルズ・インコーポレイテッド セレジリン投与による末梢ニューロパシーの予防および治療方法
AU1359801A (en) 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
RU2004134575A (ru) 2005-07-20
RU2318812C2 (ru) 2008-03-10
ATE440821T1 (de) 2009-09-15
JP4322685B2 (ja) 2009-09-02
PT1501804E (pt) 2009-10-29
HRP20040952A2 (en) 2005-06-30
ES2329354T3 (es) 2009-11-25
AU2003227614A1 (en) 2003-11-10
AU2003227614B2 (en) 2008-06-26
UY27786A1 (es) 2003-10-31
WO2003091219A1 (en) 2003-11-06
JP2005533761A (ja) 2005-11-10
NO20044571L (no) 2004-10-22
KR100681585B1 (ko) 2007-02-09
US6818774B2 (en) 2004-11-16
IL164677A0 (en) 2005-12-18
AR039651A1 (es) 2005-03-02
GT200300095A (es) 2004-01-15
SI1501804T1 (sl) 2009-12-31
DE60328978D1 (de) 2009-10-08
HK1080836A1 (en) 2006-05-04
BR0309562A (pt) 2005-02-15
MXPA04010537A (es) 2005-01-25
PE20040594A1 (es) 2004-08-30
TW200307670A (en) 2003-12-16
KR20040104628A (ko) 2004-12-10
CA2483461A1 (en) 2003-11-06
MY133527A (en) 2007-11-30
CN1310890C (zh) 2007-04-18
ZA200408281B (en) 2005-10-14
PL373697A1 (en) 2005-09-05
PA8572001A1 (es) 2003-12-10
CA2483461C (en) 2010-12-21
EP1501804A1 (en) 2005-02-02
NZ535885A (en) 2007-05-31
EP1501804B1 (en) 2009-08-26
US20030225122A1 (en) 2003-12-04
TWI278451B (en) 2007-04-11
CN1649844A (zh) 2005-08-03

Similar Documents

Publication Publication Date Title
DE60320933D1 (de) Rho-kinase inhibitoren
DK1534290T3 (da) Hidtil ukendte kinasehæmmere
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DK1505963T3 (da) Hepatitis C-inhibitorer
DE60234125D1 (de) E inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
DK1501804T3 (da) Isoquinolinderivat MAO-B-inhibitorer
NO20034955L (no) Korrosjonsinhibitor
ATA1572002A (de) Managementspleisskassette
ATE457299T1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
NO20044269L (no) Smamolekylaere inntrengningsinhibitorer
DE60302827D1 (de) Hochgeschwindigheitfräsmaschine
FI20021957A (fi) Lipeäruisku
ATE373648T1 (de) Nf-kappab-inhibitoren
ATA4142004A (de) Trägerverbau
ATA19152002A (de) Hubkupplung
DE60310151D1 (de) Positionsgeber
DE60307471D1 (de) Hemmung
DE60320694D1 (de) Positionsgeber
ITMI20021327A1 (it) Nuove ossialchilpiperazine
AT5889U3 (de) Brennholzspleisser
ATA16872002A (de) Zwischenstück
NO20031725D0 (no) Borefikstur
NO20043433L (no) Fremgangsmate
DE50311554D1 (de) Filterhalter